PHARMACEUTICAL PRODUCT DEVELOPMENT INC Exchange Rate Effect on Cash
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Exchange Rate Effect on Cash of -$7.07 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents · last filed 2011-11-02
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC effect of exchange rate on cash and cash equivalents for the quarter ending 2011-03-31 was $9.05M.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC effect of exchange rate on cash and cash equivalents for the quarter ending 2010-03-31 was -$8.98M.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC effect of exchange rate on cash and cash equivalents for fiscal 2010 was -$4.42M, a 123.64% decline from fiscal 2009.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC effect of exchange rate on cash and cash equivalents for fiscal 2009 was $18.70M.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC effect of exchange rate on cash and cash equivalents for fiscal 2008 was -$24.67M.
| Period end | Effect of Exchange Rate on Cash and Cash Equivalents 3 month | Effect of Exchange Rate on Cash and Cash Equivalents 6 month | Effect of Exchange Rate on Cash and Cash Equivalents 9 month | Effect of Exchange Rate on Cash and Cash Equivalents 12 month |
|---|---|---|---|---|
| 2011-09-30 | -$7.07M 10-Q · filed 2011-11-02 | |||
| 2011-06-30 | $13.17M 10-Q · filed 2011-08-04 | |||
| 2011-03-31 | $9.05M 10-Q · filed 2011-05-03 | |||
| 2010-12-31 | -$4.42M 10-K · filed 2011-02-25 | |||
| 2010-09-30 | -$1.54M 10-Q · filed 2011-11-02 | |||
| 2010-06-30 | -$20.04M 10-Q · filed 2011-08-04 | |||
| 2010-03-31 | -$8.98M 10-Q · filed 2011-05-03 | |||
| 2009-12-31 | $18.70M 10-K · filed 2011-02-25 | |||
| 2009-09-30 | $19.00M 10-Q · filed 2010-11-05 | |||
| 2009-06-30 | $13.35M 10-Q · filed 2010-08-06 | |||
| 2008-12-31 | -$24.67M 10-K · filed 2011-02-25 |